Statistics

Total Visits

Views
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial61

Select a period of time:

Number of views in the range

Views
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial23

Views

Views
June 20250
July 202515
August 20251
September 20251
October 20252
November 20253
December 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil11
United States6
Argentina1
Austria1
Barbados1
Mexico1
Trinidad and Tobago1
South Africa1
 

Top cities views

Views
Belém2
Belo Horizonte1
Brumadinho1
Chaguanas1
Culiacán1
Des Moines1
Elizabeth1
Fayetteville1
Franca1
Jaguariaíva1